| Novel risk factors related to cancer in scleroderma D Bernal-Bello, JG de Tena, A Guillén-del Castillo, A Selva-O'Callaghan, ... Autoimmunity Reviews 16 (5), 461-468, 2017 | 68 | 2017 |
| Imatinib for COVID-19: a case report A Morales-Ortega, D Bernal-Bello, C Llarena-Barroso, B Frutos-Pérez, ... Clinical Immunology (Orlando, Fla.) 218, 108518, 2020 | 41 | 2020 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 27 | 2023 |
| Imatinib might constitute a treatment option for lung involvement in COVID-19 D Bernal-Bello, B Jaenes-Barrios, A Morales-Ortega, JM Ruiz-Giardin, ... Autoimmunity Reviews 19 (7), 102565, 2020 | 24 | 2020 |
| Systemic sclerosis, breast cancer and calcium channel blockers: a new player on the scene? D Bernal-Bello, J Garcia de Tena, C Simeon-Aznar, V Fonollosa-Pla Autoimmunity Reviews 13 (8), 880-881, 2014 | 16 | 2014 |
| Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID‐19 patients MA Duarte‐Millán, N Mesa‐Plaza, M Guerrero‐Santillán, ... Journal of Medical Virology 94 (4), 1540-1549, 2022 | 15 | 2022 |
| Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: derivation and … M Rubio-Rivas, X Corbella, A Guillén-del-Castillo, CT Vilella, ... Autoimmunity Reviews 19 (5), 102507, 2020 | 15 | 2020 |
| Imatinib in COVID-19: hope and caution D Bernal-Bello, A Morales-Ortega, AI Farfán-Sedano, JG de Tena, ... The Lancet Respiratory Medicine 9 (9), 938-939, 2021 | 12 | 2021 |
| Early clinical experience with imatinib in COVID-19: Searching for a dual effect A Morales-Ortega, L Rivas-Prado, B Frutos-Pérez, B Jaenes-Barrios, ... Journal of Infection 82 (5), 186-230, 2021 | 9 | 2021 |
| Comparative study of vaccinated and unvaccinated hospitalised patients: A retrospective population study of 500 hospitalised patients with SARS-CoV-2 infection in a Spanish … JM Ruiz-Giardin, M Rivilla, N Mesa, A Morales, L Rivas, A Izquierdo, ... Viruses 14 (10), 2284, 2022 | 7 | 2022 |
| Dosis altas de corticoides sistémicos en pacientes ingresados por exacerbación de enfermedad pulmonar obstructiva crónica. Un estudio de cohortes JA Rueda-Camino, D Bernal-Bello, J Canora-Lebrato, L Velázquez-Ríos, ... Revista Clínica Española 217 (9), 504-509, 2017 | 6 | 2017 |
| COVID‐19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors A Morales‐Ortega, JG de Tena, B Frutos‐Pérez, B Jaenes‐Barrios, ... Cancer 127 (11), 1937, 2021 | 4 | 2021 |
| High doses of systemic corticosteroids in patients hospitalized for exacerbation of chronic obstructive pulmonary disease. A cohort study JA Rueda-Camino, D Bernal-Bello, J Canora-Lebrato, L Velázquez-Ríos, ... Revista Clínica Española (English Edition) 217 (9), 504-509, 2017 | 4 | 2017 |
| Afectación atípica de palmas y plantas en la neumonía por varicela D Bernal-Bello, J García de Tena, L Abejón-López, T Megino-Moreno, ... Revista Clínica Española 212 (4), 0-0, 2012 | 4 | 2012 |
| Hyperparathyroidism shows its hand: findings of osteitis fibrosa cystica L Rivas-Prado, A Morales-Ortega, S Allodi-de la Hoz, D Bernal-Bello The Lancet 397 (10288), 1914, 2021 | 3 | 2021 |
| Baricitinib or imatinib in hospitalized COVID‐19 patients: Results from COVINIB, an exploratory randomized clinical trial A Morales‐Ortega, AI Farfán‐Sedano, JV San Martín‐López, ... Journal of Medical Virology 95 (2), e28495, 2023 | 2 | 2023 |
| HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID‐19 P Castro‐Santos, A Rojas‐Martinez, JA Riancho, P Lapunzina, C Flores, ... HLA, 2023 | 2 | 2023 |
| Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy D Bernal-Bello, I Guerra-Pérez, L Alegre-Zahonero biomedical journal 45 (5), 847, 2022 | 2 | 2022 |
| SAT0276 study of the epidemiological, clinical and analytical characteristics in patients with systemic sclerosis and cancer in Vall D’hebron Hospital MR Herrera, AG del Castillo, EC Moraga, DB Bello, JH Cubero, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1214-1215, 2019 | 2 | 2019 |
| Reversed halo sign as initial manifestation of interstitial pneumonitis associated with Sjögren’s syndrome MA Duarte-Millan, D Bernal-Bello, JA Rueda-Camino, S Martín-Barón, ... The Egyptian Rheumatologist 39 (3), 187-189, 2017 | 2 | 2017 |
